SEOM clinical guidelines for the treatment of early breast cancer.
The incidence is increasing due to mammographic screening and an ageing population. In some countries the mortality rate has decreased especially in middleaged and younger groups because of improved treatment and possibly earlier detection. However, breast cancer is still the leading cause of cancer-related death in European women. The purpose of this work was to elaborate a Spanish Society of Medical Oncology guideline on pharmacologic interventions for early breast cancer (BC). We have compiled the latest advances in the management of this pathology either in the adjuvant and neoadjuvant setting, cytostatic and hormonal treatment, so that in a simple way could be useful to oncologist, residents and other related specialties.
del Barco Berrón
Sonia
S
Servicio de Oncología Médica, Instituto Catalán de Oncologia (ICO), Hospital Dr. Josep Trueta, Gerona, Spain.
Ciruelos Gil
Eva
E
Tusquets Trías de Bes
Ignacio
I
Muñoz Mateu
Montserrat
M
Sánchez Rovira
Pedro
P
Rodríguez Lescure
Álvaro
Á
Isla Casado
Dolores
D
D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D001943:Breast Neoplasms / Q000473:pathology / Q000628:therapy*; D002277:Carcinoma / Q000473:pathology / Q000628:therapy*; D017024:Chemotherapy, Adjuvant / Q000379:methods / Q000706:statistics & numerical data; D002986:Clinical Trials as Topic; D018450:Disease Progression; D005260:Female; D006801:Humans; D008495:Medical Oncology / Q000331:legislation & jurisprudence / Q000379:methods*; D012955:Societies, Medical; D013030:Spain
D018931:Antineoplastic Agents, Hormonal